In patients with esophageal squamous cell carcinoma with invasion into the muscularis mucosa (pMM-ESCC) with lymphovascular invasion (LVI), the Japan Esophageal Society recommends additional treatment
In patients with esophageal squamous cell carcinoma with invasion into the muscularis mucosa (pMM-ESCC) with lymphovascular invasion (LVI), the Japan Esophageal Society recommends additional treatment